Polpharma Pharmaceutical Works - API Manufacturer

drukuj

Current API product portfolio   

Enalapril maleate

Specification:
  • USP
chemical name: (2S)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl] pyrrolidine-2-carboxylic acid (Z)-butenedioate
molecular formula: C24H32N2O9
structural formula: structural formula
molecular weight: 492.5
CAS Registery number: 76095-16-4

General information:

Off-white, crystalline powder. Melts at about 144°. Practically insoluble in nonpolar organic solvents; slightly soluble in semipolar organic solvents; sparingly soluble in water; soluble in alcohol; freely soluble in methanol and in dimethylformamide.

TESTS REQUIERMENTS METHODS
Identification:

- IR spectrum


- HPLC


comparison with reference substance spectrum

the retention time of the major peak in the chromatogram of test solution corresponds to that in the chromatogram of standard solution
USP
Specific rotation - 41.00 to – 43.50 USP
Loss on drying not more than 1.0% USP
Residue on ignition not more than 0.2% USP
Heavy metal not more than 0.001% USP
Chromatographic purity:

- single impurity about relative retention time about 1.10

- each other single impurity

- total impurities



not more than 1.0%


not more than 0.3%

not more than 2%

USP
Residual solvents:

- methylene chloride

- cyclohexane

- ethanol

- isopropanol


not more than 300 ppm

not more than 2000 ppm

not more than 2500 ppm

not more than 2500 ppm
POLPHARMA
Content of enalapril maleate calculated on dried substance 98.0% - 102.0% USP
« back to API list

Latest news

CEP for Baclofen available

Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...

Polpharma – the most innovative company in Poland

Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...

Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex

Friday, 08-10-2010
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex for the...

Co-operation between Polpharma and RPG Life Sciences

Tuesday, 05-10-2010
RPGLS and Polpharma announced their co-operation in the development and manufacture of Active...
© POLPHARMA S.A. All rights reserved.
Realizacja: Ideo